Effects of Bacillus Calmette-Guérin (BCG Moscow) vaccination on white blood cell count: results of a randomized clinical trial
Main Article Content
Abstract
Introduction: Bacillus Calmette-Guérin (BCG) vaccination induces innate and specific responses that protect against some severe forms of tuberculosis and have nonspecific effects against other infections. Objective: To evaluate whether revaccination with BCG Moscow is associated with serum increase in total and differential leukocytes. Methods: We conducted an analytical study on the white blood cell count of 156 participants (BCG revaccination group: 80; Control group: 76) of a randomized clinical trial investigating BCG revaccination for the prevention or reduction of complications associated with COVID-19. Blood samples were collected before randomization and after 15 days of intervention. Values were expressed as mean (μ) and standard deviation, using paired t-tests and Student's t-test. Results: BCG revaccination did not alter leukocyte levels between revaccinated (μ, 6019.74±1865.33) and non-revaccinated groups (μ, 6278.75±1823.87), p=0.94. Stratification by sex, obesity, and age did not significantly affect white blood cell levels. Conclusion: Revaccination with BCG Moscow did not stimulate leukocyte production.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY) that allows others to share and adapt the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.References
Foster M, Hill PC, Setiabudiawan TP, Koeken VACM, Alisjahbana B, van Crevel R. BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines. Immunological Rev. 2021;301(1):122-44. https://doi.org/10.1111/imr.12965
World Health Organization (WHO). BCG vaccines: WHO position paper. Available from: https://apps.who.int/iris/handle/10665/260307
Biering-Sørensen S, Jensen KJ, Monterio I, Ravn H, Aaby P, Benn CS. Rapid protective effects of early BCG on neonatal mortality among low birth weight boys: observations from randomized trials. J Infect Dis. 2018;217(5):759-66. https://doi.org/10.1093/infdis/jix612
Stensballe LG, Nantea E, Jensenc IP, Kofoeda PE, Poulsena A, Jensena H, et al. Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: A beneficial effect of BCG vaccination for girls. Community-based case-control study. Vaccine. 2005;23(10):1251-7. https://doi.org/10.1016/j.vaccine.2004.09.006
Giamarellos-Bourboulis EJ, Tsilika M, Moorlag S, Antonakos N, Kotsaki A, Domínguez-Andrés J, et al. Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly. Cell. 2020;183(2):315-23. https://doi.org/10.1016/j.cell.2020.08.051
Nemes E, Geldenhuys H, Rozot V, Rutkowski KT, Ratangee F, Bilek N, et al. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination. N Engl J Med. 2018;379(2):138-49. https://doi.org/10.1056/NEJMoa1714021
Netea MG, Domínguez-Andrés J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20:375-88. https://doi.org/10.1038/s41577-020-0285-6
Moorlag SJCGM, van Deuren RC, van Werkhoven CH, Jaeger M, Debisarun P, Taks E, et al. Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: A Retrospective Cohort Study. Cell Rep Med. 2020;1(5):100073. https://doi.org/10.1016/j.xcrm.2020.100073
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Zhu B, Feng X, Jiang C, Mi S, Yang L, Zhao Z et al. Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study. BMC Infect Dis. 2021;21(1):574. https://doi.org/10.1186/s12879-021-06277-3
Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y, Otazu GH. Correlation between universal BCG vaccination policy and reduced mortality for COVID-19. medRxiv. 2020. https://doi.org/10.1101/2020.03.24.20042937
Kinoshita M, Tanaka M. Impact of Routine Infant BCG Vaccination on COVID-19. J Infect. 2020;81(4):625-33. https://doi.org/10.1016/j.jinf.2020.08.013
Madsen AMR, Schaltz-Buchholzer F, Benfield T, Bjerregaard-Andersen M, Dalgaard LS, Dam C, et al. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomized controlled trial in Denmark. Trials. 2020;21(1):799. https://doi.org/10.1186/s13063-020-04714-3
Junqueira-Kipnis AP, Anjos LRB, Barbosa LCS, Costa AC, Borges JCMB, Cardoso ARO, et al. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020;21(1):881. https://doi.org/10.1186/s13063-020-04822-0
Upton CM, van Wijk RC, Mockeliunas L, Simonsson USH, McHarry K, van den Hoogen G, et al. Safety and efficacy of BCG re-vaccination about COVID-19 morbidity in healthcare workers: A double- blind, randomised, controlled, phase 3 trial. EClinicalMedicine. 2022;48:101414. https://doi.org/10.1016/j. eclinm.2022.101414
Koeken VA, Bree LCJ, Mourits VP, Moorlag SJ, Walk J, Cirovic B, et al. BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner. J Clin Invest. 2020;130(1):5591-602. https://doi.org/10.1172/JCI133935
Anjos LRB, Costa AC, Cardoso AROC, Guimarães RA, Rodrigues RL, Ribeiro KM, et al. Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial. Front Immunol. 2022;13:841868. https://doi.org/10.1093/infdis/jiu508
Chambers JM, Cleveland WS, Kleiner B, Tukey PA. Graphical methods for data analysis, New York: Chapman,1983.
World Health Organization. Obesity. Available from: https://www.who.int/health-topics/obesity#tab=tab_1
Jensen KJ, Larsen N, Biering-Sørensen S, Andersen A, Eriksen HB, Monteiro I, et al. Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: A randomized-controlled trial. J Infect Dis. 2015;211(6):956-67. https://doi.org/10.1093/infdis/jiu508
Jensen SK, Jensen TM, Birk NM, Stensballe LG, Benn CS, Jensen KJ, et al. Bacille Calmette-Guérin vaccination at birth and differential white blood cell count in infancy. A randomised clinical trial. Vaccine. 2020;38(11):2449-55. https://doi.org/10.1016/j.vaccine.2020.02.006
Blok BA, Bree CJ, Diavatopoulos DA, Langereis JD, Joosten LAB, Aaby P, et al. Interacting, nonspecific, immunological effects of bacille calmette-guérin and tetanus-diphtheriapertussis inactivated polio vaccinations: An explorative, randomized trial. Clin Infect Dis. 2020;70(3):455-63. https://doi.org/10.1093/cid/ciz246
Cortez AO, Melo AC, Neves LO, Resende KA, Camargos P. Tuberculosis in Brazil: one country, multiple realities. J Bras Pneumol. 2021;47(2):e20200119. https://doi.org/10.36416/1806-3756/e20200119
Borges KCM, Costa AC, Barbosa LCS, Ribeiro KM, Anjos LRB, Kipnis A, et al. Tuberculosis, BCG Vaccination, and COVID-19: Are They Connected? Mini Rev Med Chem. 2022;22(12):1631-47. https://doi.org/10.2174/1389557522666220104152634
Lange C, Aaby P, Behr MA, Donald PR, Kaufmann SHE, Netea MG, et al. 100 years of Mycobacterium bovis bacille Calmette-Guérin. Lancet Infect Dis. 2022;22(1):e2-e12. https://doi.org/10.1016/S1473-3099(21)00403-5
Schaltz-Buchholzer F, Bjerregaard-Andersen M, Øland CB, Golding C, Stjernholm EB, Monteiro I, et al. Early Vaccination with Bacille Calmette-Guérin-Denmark or BCG-Japan Versus BCG-Russia to Healthy Newborns in Guinea-Bissau: a randomized controlled trial. Clin Infect Dis. 2020;71(8):1883-93. https://doi.org/10.1093/cid/ciz1080
Gonzalez-Perez M, Sanchez-Tarjuelo R, Shor B, Nistal-Villan E, Ochando J. The BCG Vaccine for COVID-19: First Verdict and Future Directions. Front Immunol. 2021;12:632478. https://doi.org/10.3389/fimmu.2021.632478
Flanagan KL, Best E, Crawford NW, Giles M, Koirala A, Macartney K, et al. Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines. Front Immunol. 2020;11:579250. https://doi.org/10.3389/fimmu.2020.579250
Saade E, Canaday DH, Davidson HE, Han LF, Gravenstein S. Chapter 3- Special Considerations for vaccines and the elderly. Vaccinations. 2019;35-53. https://doi.org/10.1016/B978-0-323-55435-0.00003-3
Jackson LA, Gurtman A, Cleeff M, Frenck RW, Treanor J, Jansen KU, et al. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Vaccine. 2013;31(13):3594-602. https://doi.org/10.1016/j.vaccine.2013.04.084
Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. https://doi.org/10.1001/jama.2020.2648
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669-77. https://doi.org/10.1016/S1473-3099(20)30243-7
Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine. 2015;33(36):4422-9. https://doi.org/10.1016/j.vaccine.2015.06.101
Falagas ME, Kompoti, M. Obesity and infection. Lancet Infect Dis. 2006;6(7):438-46. https://doi.org/10.1016/S1473-3099(06)70523-0
Kompaniyets L, Pennington AF, Goodman AB, Rosenblum HG, Belay B, Ko JY, et al. Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021. Prev Chronic Dis. 2021;18:E66. https://doi.org/10.5888/pcd18.210123
Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: A global perspective on epidemiology and biological relationships. Obesity Rev. 2020;21(11):e13128. https://doi.org/10.1111/obr.13128
BevilacquaA, Li Z, Ho PC. Metabolic dynamics instruct CD8(+) T-cell differentiation and functions. Eur J Immunol. 2022;52(4):541-9. https://doi.org/10.1002/eji.202149486
Carpenter E, Fray L, Gormley E. Cellular responses and Mycobacterium bovis BCG growth inhibition by bovine lymphocytes. Immunol Cell Biol. 1997;75(6):554-60. https://doi.org/10.1038/icb.1997.86
Wang J, Yin Y, Wang X, Pei H, Kuai S, Gu L, et al. Ratio of monocytes to lymphocytes in peripheral blood in patients diagnosed with active tuberculosis. Braz J Infec Dis. 2015;19(2):125-31. https://doi.org/10.1016/j.bjid.2014.10.008
da Costa AC, de Souza Barbosa LC, Kipnis A, Junqueira-Kipnis AP. A expressão diminuída de CD314 pelas células NK se correlaciona com sua capacidade de responder pela produção de IFN-γ após a vacinação com BCG Moscou e está associada a respostas imunológicas precoces distintas. Vacinas. 2023;11(8):1297. https://doi.org/10.3390/vaccines11081297